Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-13

Clinical Trial Update: Efficacy of Natural Extract 2007RD01 Combined With Saw Palmetto in Benign Prostatic Hyperplasia Patients Compared to Saw Palmetto [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated whether combining Natural Extract 2007RD01 with Saw Palmetto improves outcomes in Benign Prostatic Hyperplasia compared with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Natural Extract 2007RD01
  • Saw Palmetto (Serenoa repens)

Snippet

Sponsor: innoVactiv Inc. | Conditions: Benign Prostatic Hyperplasia | Phase 2 | Status: COMPLETED